American private equity (PE) firm The Carlyle Group will sell some of its stake in diagnostics chain Metropolis Healthcare Ltd in the latter’s initial public offering (IPO) that opens on 3 April.
The Metropolis IPO is a pure offer for sale of 13.685 million shares, including a sale of up to 6.272 million shares by promoter Sushil Shah, besides another 7.412 million shares by CA Lotus Investments, an entity managed by Carlyle.
